JTL Industries to add 3 lakh MTPA capacity with new ERW pipe manufacturing line
The new ERW line will enable the production of a wide range of pipes, including: Round pipes ranging from 6' to 20' (168 mm to 508 mm OD)
Square sections from 130 mm x 130 mm to 400 mm x 400 mm
Rectangular sections from 100 mm x 160 mm to 300 mm x 500 mm
Thickness range between 4 mm and 16 mm
This expansion will boost JTL's manufacturing capacity by 3,00,000 metric tonnes per annum (MTPA). The company expects the line to be fully installed and operational within the next 12 months, marking a key milestone in its growth strategy to meet rising demand in both domestic and international steel pipe markets.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
13 hours ago
- Business Upturn
Finance ministry announces sweeping GST reforms to boost economy and ease compliance; focus on structural changes, rate rationalisation
The finance ministry has set the stage for a significant overhaul of the Goods and Services Tax (GST) regime, outlining reforms built on three key pillars — structural changes, rate rationalisation, and improving the ease of living for citizens. According to the ministry, the proposed changes will include rationalisation of tax rates to ensure benefits reach all sections of society, while also addressing long-standing issues such as classification-related disputes and inverted duty structures in specific sectors. Officials say the reforms are aimed at ensuring greater rate stability and enhancing the ease of doing business, measures that could boost investor confidence and economic momentum. The ministry added that the changes are expected to strengthen key sectors of the economy, stimulate activity across industries, and pave the way for sectoral expansion. The announcement signals one of the most ambitious GST reform drives since the tax's rollout in 2017, with the government looking to create a simpler, fairer, and more business-friendly tax system ahead of the festive season. Ahmedabad Plane Crash News desk at
Business Upturn
16 hours ago
- Business Upturn
Independence Day 2025: PM Narendra Modi makes 10 big announcements
By News Desk Published on August 15, 2025, 09:08 IST Last updated August 15, 2025, 09:13 IST On the occasion of India's 79th Independence Day, Prime Minister Narendra Modi addressed the nation from the Red Fort on Friday, unveiling 10 major announcements spanning national security, economic reforms, defence, and employment. Modi reaffirmed a tough stance on national security, declaring on the Indus Waters Treaty that 'blood and water won't flow together' and emphasising 'zero tolerance to terror' through deep strikes under Operation Sindoor. The Prime Minister also announced a new defence doctrine, pledging to retaliate 'on our terms.' In the defence sector, he revealed plans for Made-in-India fighter jet engines and a broader push for self-reliance under the Atmanirbhar Bharat initiative. The government will also launch the 'Samudra Manthan' mission to boost domestic oil and gas exploration. On the economic front, Modi said GST 2.0 would be rolled out by Diwali with lower rates and reduced compliance, while linking recent credit rating upgrades to growing global trust in India. He assured the agricultural community that there would be no anti-farmer, fisher, or dairy policies. The Prime Minister also announced the launch of a Rozgar Yojana aimed at creating one crore jobs across sectors, underscoring employment as a key priority. These announcements set the tone for the government's strategic and economic agenda in the coming months, with a focus on national strength, economic growth, and social welfare. Ahmedabad Plane Crash News desk at
Yahoo
a day ago
- Yahoo
AbbVie expands North Chicago API production with $195m investment
AbbVie is investing $195m to strengthen domestic active pharmaceutical ingredient (API) production within the US, with the expansion of its manufacturing plant in North Chicago, Illinois. This development is part of a larger commitment by the company to invest more than $10bn in US capital for innovation and critical manufacturing capacity enhancement. The process of API manufacturing involves creating the active components that are essential for the therapeutic effects of medications. AbbVie aims to enhance its chemical synthesis capabilities in the country with this new facility, which will support current and future neuroscience, immunology and oncology medicines' domestic production. AbbVie chairman CEO Robert Michael stated: "Over the next decade, AbbVie will expand production of API, drug product, peptides and medical devices in the US to support future medical breakthroughs. "This is an important step to maintain US leadership in pharmaceutical innovation and deliver next-generation medicines that make a remarkable impact on patients' lives." The construction on the new API facility in North Chicago is set to commence in autumn 2025, with the site fully operational by 2027. This development will enlarge AbbVie's current manufacturing presence in the US. The company creates more than 6,000 jobs across 11 sites and supports many more through its supplier networks. Illinois Governor JB Pritzker stated: 'AbbVie's decision to expand its manufacturing footprint in Illinois is a testament to our state's world-class workforce, infrastructure, cutting-edge research institutions and location that keeps businesses connected to the nation and the world. 'As a global leader in pharmaceuticals, AbbVie's investment in Illinois bolsters our world-class biomanufacturing ecosystem and creates jobs while it innovates next-generation medicines.' In August 2025, Genmab and AbbVie announced that their subcutaneous bispecific antibody, Epkinly (epcoritamab), had met its dual primary endpoints as a second-line combination therapy for relapsed or refractory (r/r) follicular lymphoma (FL). "AbbVie expands North Chicago API production with $195m investment" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
